All Posts Tagged With: "disability"

Linda’s comment:  I suggest you copy and paste this and/or print out and take to your doctors or any healthcare practitioners and make sure they are recording things properly in your charts.  When you know your symptoms are attributed to Lyme disease, make sure this is noted.

In general, social security does not make decisions on a diagnosis, but on the restrictions and functional limitations a person has that results on their inability to work based on any training, education and experience the person had in the past.
 
Because Lyme disease is not listed in the “blue book”, it is even more important for those with Lyme disease to do the following.
Make sure all treating physicians understand the importance of documenting actual functional limitations in the actual patient notes.
 
Many physicians actually write “non-descriptive” patient notes which later are determined to be useless for SSDI purposes.
 
If a Lyme patient is suffering from neurological deficits that result in loss of balance and coordination, this should be clearly indicated in the patient record as attributable to Lyme disease.

One in six children today suffer from a neurodevelopmental disorder. This well referenced article from Lancet contains valuable information to enable you to educate yourselves in regard our need today for continual detoxification. 

Institute of Public University of Southern Denmark, Odense, Denmark (Prof P Grandjean MD); Department of Environmental Health, Harvard School of Public Health, Boston, MA, USA (P Grandjean); Department of Community Medicine (Prof PJ Landrigan MD); and Department of Pediatrics, Mount Sinai School of Medicine, New York, NY, USA
Neurodevelopmental disorders such as autism, attention deficit disorder, mental retardation, and cerebral palsy are common, costly, and can cause lifelong disability. Their causes are mostly unknown. A few industrial chemicals (eg, lead, methylmercury, polychlorinated biphenyls [PCBs], arsenic, and toluene) are recognised causes of neuro-developmental disorders and subclinical brain dysfunction. Exposure to these chemicals during early fetal development can cause brain injury at doses much lower than those affecting adult brain function. Recognition of these risks has led to evidence-based programmes of prevention, such as elimination of lead additives in petrol. Although these prevention campaigns are highly successful, most were initiated only after substantial delays. Another 200 chemicals are known to cause clinical neurotoxic effects in adults. Despite an absence of systematic testing, many additional chemicals have been shown to be neurotoxic in laboratory models. The toxic effects of such chemicals in the developing human brain are not known and they are not regulated to protect children. The two main impediments to prevention of neurodevelopmental deficits of chemical origin are the great gaps in testing chemicals for developmental neurotoxicity and the high level of proof required for regulation. New, precautionary approaches that recognise the unique vulnerability of the developing brain are needed for testing and control of chemicals